Market Share of Artificial Intelligence In Medicine Industry
The overall competitive rivalry remains moderately high in the Market studied. The growing existence of big players in the industry is anticipated to intensify competitive rivalry during the projection period. Incumbents, such as IBM Watson Health, Atomwise Inc., etc., considerably influence the overall Market.
- June 2023- Stanford Medicine and Stanford Institute for Human-Centered Artificial Intelligence (HAI) launched Responsible AI for Safe and Equitable Health (RAISE-Health), intending to address critical ethical and safety issues regarding the technology. RAISE-Health will be co-led by Stanford School of Medicine Dean Lloyd Minor, M.D., and Stanford HAI co-director and computer science professor Fei-Fei Li, Ph.D. The two will establish a go-to platform for responsible AI in health and medicine, define a structured framework for ethical standards and safeguards, and regularly conduct expert discussions on the subject.
- September 2022 - AiCure announced its clinical site services program opening. The new program offers sites end-to-end, personalized support and monitoring of KPIs relating to adherence, compliance, data management, and use of technology among study participants. With this solution, AiCure provides research coordinators with proactive insights into their patient demographics to reduce risk across studies and improve workflows.
Artificial Intelligence in Medicine Market Leaders
Atomwise Inc.
Novo Nordisk A/S
Modernizing Medicine Inc.
Nano-X Imaging Ltd
Medasense Biometrics Limited
*Disclaimer: Major Players sorted in no particular order
